Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb 15;2012(2):CD008155.
doi: 10.1002/14651858.CD008155.pub2.

Surfactant for bacterial pneumonia in late preterm and term infants

Kenneth Tan  1 , Nai Ming Lai, Ajay Sharma
Affiliations

Surfactant for bacterial pneumonia in late preterm and term infants

Kenneth Tan et al. Cochrane Database Syst Rev. .

Abstract

Background: Pulmonary surfactant is an important part of the host defence against respiratory infections. Bacterial pneumonia in late preterm or term newborn infants often leads to surfactant deficiency or dysfunction, as surfactant is either inactivated or peroxidated. Studies of animal models of pneumonia and clinical case reports suggest that exogenous surfactant might be beneficial to infants with bacterial pneumonia.

Objectives: To assess the effect of exogenous surfactant treatment on mortality and pulmonary complications in infants with bacterial pneumonia.

Search methods: We used standard Cochrane Collaboration methodology to conduct our search of databases. We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2011, Issue 6); MEDLINE (accessed via Ovid SP June 2011); EMBASE (via Ovid SP 1980 to June 2011); and CINAHL Plus (accessed via EBSCOHost June 2011).

Selection criteria: We limited our search to randomised and quasi-randomised trials of surfactant replacement therapy in infants > 35 weeks gestation with bacterial pneumonia in the first 28 days of life. The primary outcome measures were death, time to resolution of pneumonia, incidence of chronic lung disease, pneumothoraces and pulmonary haemorrhage.

Data collection and analysis: We assessed all studies with predefined criteria as to whether they were eligible for inclusion. We extracted data using RevMan 5 (RevMan 2011). We used the standard Cochrane Collaboration methodology for data collection and analysis to assess risk of bias, heterogeneity, treatment effect, missing data and reporting bias where appropriate.

Main results: We did not identify any studies that met our inclusion criteria.

Authors' conclusions: There is no evidence from randomised controlled trials (RCTs) to support or refute the efficacy of surfactant in near-term and term infants with proven or suspected bacterial pneumonia. RCTs are still required to answer this question.

PubMed Disclaimer

Conflict of interest statement

None

Update of

  • doi: 10.1002/14651858.CD008155

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies excluded from this review

Brehmer 1993 {published data only}
    1. Brehmer U, Jorch G. Surfactant therapy in severe neonatal respiratory failure‐multicenter study‐III. Surfactant therapy in 41 premature infants < 34 weeks with suspected congenital infection (case‐control analysis). Klinische Padiatrie 1993;205:78‐82. - PubMed
Herting 2000 {published data only}
    1. Herting E, Gefeller O, Land M, Sonderen L, Harms K, Robertson B. Surfactant treatment of neonates with respiratory failure and group B streptococcal infection; the Collaborative European Multicenter Study Group. Pediatrics 2000;106:957‐64. - PubMed
Herting 2002 {published data only}
    1. Herting E, Möller O, Schiffmann JH, Robertson B. Surfactant improves oxygenation in infants and children with pneumonia and acute respiratory distress syndrome. Acta Paediatrica 2002;91:1174‐8. - PubMed

Additional references

Apisarnthanarak 2003
    1. Apisarnthanarak A, Holzmann‐Pazgal G, Hamvas A, Olsen MA, Fraser VJ. Ventilator‐associated pneumonia in extremely preterm neonates in a neonatal intensive care unit: characteristics, risk factors, and outcomes. Pediatrics 2003;112:1283‐9. - PubMed
Balaraman 1998
    1. Balaraman V, Meister J, Ku TL, Sood SL, Tam E, Killeen J, et al. Lavage administration of dilute surfactants after acute lung injury in neonatal piglets. American Journal of Respiratory and Critical Care Medicine 1998;158:12‐7. - PubMed
Baltimore 2003
    1. Baltimore RS. The difficulty of diagnosing ventilator‐associated pneumonia. Pediatrics 2003;112:1420‐21. - PubMed
Bouhafs 1999
    1. Bouhafs RK, Jarstrand C. Lipid peroxidation of lung surfactant by bacteria. Lung 1999;177:101‐10. - PubMed
Bouhafs 2004
    1. Bouhafs RK, Jarstrand C, Robertson B. Lipid peroxidation of lung surfactant in experimental neonatal group B streptococcal pneumonia. Lung 2004;182:61‐72. - PubMed
Campbell 1996
    1. Campbell JR. Neonatal pneumonia. Seminars in Respiratory Infections 1996;11:155‐62. - PubMed
Chan 2007
    1. Chan YR, Morris A. Molecular diagnostic methods in pneumonia. Current Opinion in Infectious Diseases 2007;20:157‐64. - PubMed
Cordero 2002
    1. Cordero L, Ayers LW, Miller RR, Seguin JH, Coley BD. Surveillance of ventilator‐associated pneumonia in very‐low‐birth‐weight infants. American Journal of Infection Control 2002;30:32‐9. - PubMed
Cowan 1991
    1. Cowan F, Whitelaw A, Wertheim D, Silverman M. Cerebral blood flow velocity changes after rapid administration of surfactant. Archives of Disease in Childhood 1991;66:1105‐9. - PMC - PubMed
Dargaville 2005
    1. Dargaville PA, Mills JF. Surfactant therapy for meconium aspiration syndrome: current status. Drugs 2005;65:2569‐91. - PubMed
Dear 2005
    1. Dear PRF. Infection in the newborn. In: JM Rennie editor(s). Roberton's Textbook of Neonatology. 4th Edition. Elsevier Churchill Livingstone, 2005:1011‐92.
Duke 2005
    1. Duke T. Neonatal pneumonia in developing countries. Archives of Disease in Childhood. Fetal and Neonatal Edition 2005;90:F211‐9. - PMC - PubMed
El‐Shahed 2007
    1. El‐Shahed AI, Dargaville P, Ohlsson A, Soll RF. Surfactant for meconium aspiration syndrome in full term/near term infants. Cochrane Database of Systematic Reviews 2007. [DOI: 10.1002/14651858.CD002054.pub2] - DOI - PubMed
Fetter 1995
    1. Fetter WP, Baerts W, Bos AP, Lingen RA. Surfactant replacement therapy in neonates with respiratory failure due to bacterial sepsis. Acta Paediatrica 1995;84:14‐6. - PubMed
Fok 1998
    1. Fok TF, Al‐Essa M, Dolovich M, Rasid F, Kirpalani H. Nebulisation of surfactants in an animal model of neonatal respiratory distress. Archives of Disease in Childhood. Fetal and Neonatal Edition 1998;78:F3‐9. - PMC - PubMed
Forest 1986
    1. Forest JC, Lariviere F, Dolce P, Masson M, Nadeau L. C‐reactive protein as biochemical indicator of bacterial infection in neonates. Clinical Biochemistry 1986;19:192‐4. - PubMed
Gan 2001
    1. Gan X, Jarstrand C, Herting E, Berggren P, Robertson B. Effect of surfactant and specific antibody on bacterial proliferation and lung function in experimental pneumococcal pneumonia. International Journal of Infectious Diseases 2001;5:9‐18. - PubMed
Goerke 1998
    1. Goerke J. Pulmonary surfactant: functions and molecular composition. Biochimica et Biophysica Acta (BBA) ‐ Molecular Basis of Disease 1998;1408:79‐89. - PubMed
Guyatt 2008
    1. Guyatt G, Jaeschke R, Prasad K, Cook DJ. Chapter 14: Summarizing the evidence. In: Guyatt G, Rennie D, Meade MO, Cook DJ editor(s). Users' Guides to the Medical Literature: Essentials of Evidence‐based Clinical Practice. 2nd Edition. New York: McGraw Hill Medical, 2008:253.
Harms 1994
    1. Harms K, Herting E. Successful surfactant replacement therapy in two infants with ARDS due to chlamydial pneumonia. Respiration 1994;61:348‐52. - PubMed
Herting 1994
    1. Herting E, Jarstrand C, Rasool O, Curstedt T, Sun B, Robertson B. Experimental neonatal group B streptococcal pneumonia: effect of a modified porcine surfactant on bacterial proliferation in ventilated near‐term rabbits. Pediatric Research 1994;36:784‐91. - PubMed
Herting 1999
    1. Herting E, Gan X, Rauprich P, Jarstrand C, Robertson B. Combined treatment with surfactant and specific immunoglobulin reduces bacterial proliferation in experimental neonatal group B streptococcal pneumonia. American Journal of Respiratory and Critical Care Medicine 1999;159:1862‐7. - PubMed
Higgins 2011
    1. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Horan 2008
    1. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care‐associated infection and criteria for specific types of infections in the acute care setting. American Journal of Infection Control 2008;36:309‐332. - PubMed
Jobe 2006
    1. Jobe AH. Mechanisms to explain surfactant responses. Biology of the Neonate 2006;89:298‐302. - PubMed
Jobe 2008
    1. Jobe AH. Surfactant: The basis for clinical treatment strategies. The Newborn Lung: Neonatology questions and controversies. Saunders Elsevier, 2008.
Kaiser 2004
    1. Kaiser JR, Gauss CH, Williams DK. Surfactant administration acutely affects cerebral and systemic hemodynamics and gas exchange in very‐low‐birth‐weight infants. Journal of Pediatrics 2004;144:809‐14. - PubMed
Lejeune 2005
    1. Lejeune T, Pfister RE. Surfactant lavage for extracorporeal membrane oxygenation‐requiring meconium aspiration syndrome‐a cheap alternative. European Journal of Pediatrics 2005;164:331‐3. - PubMed
LeVine 1996
    1. LeVine AM, Lotze A, Stanley S, Stroud C, O'Donnell R, Whitsett J, et al. Surfactant content in children with inflammatory lung disease. Critical Care Medicine 1996;24:1062‐7. - PubMed
Lo 2008
    1. Lo CW, Jeng MJ, Chang FY, Yang JF, Lee YS, Soong WJ, et al. Therapeutic lung lavage with diluted surfactant in neonates with severe meconium aspiration syndrome. Journal of the Chinese Medical Association 2008;71:103‐9. - PubMed
McCormack 2002
    1. McCormack FX, Whitsett JA. The pulmonary collections, SP‐A and SP‐D, orchestrate immunity in the lung. Journal of Clinical Investigation 2002;109:707‐12. - PMC - PubMed
Payne 1988
    1. Payne NR, Burke BA, Day DL, Christenson PD, Thompson TR, Ferrieri P. Correlation of clinical and pathologic findings in early onset neonatal group B streptococcal infection with disease severity and prediction of outcome. Pediatric Infectious Disease Journal 1988;7:836‐47. - PubMed
Pfister 2007
    1. Pfister RH, Soll RF, Wiswell T. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD006069.pub3] - DOI - PubMed
Raju 1993
    1. Raju TN, Langenberg P. Pulmonary hemorrhage and exogenous surfactant therapy: a meta‐analysis. Journal of Pediatrics 1993;123:603‐10. - PubMed
Rauprich 2000
    1. Rauprich P, Moller O, Walter G, Herting E, Robertson B. Influence of modified natural or synthetic surfactant preparations on growth of bacteria causing infections in the neonatal period. Clinical and Diagnostic Laboratory Immunology 2000;7:817‐22. - PMC - PubMed
RevMan 2011 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Rudiger 2001
    1. Rudiger M, Friedrich W, Rustow B, Schmalisch G, Wauer R. Disturbed surface properties in preterm infants with pneumonia. Biology of the Neonate 2001;79:73‐8. - PubMed
Seger 2009
    1. Seger N, Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD007836] - DOI - PubMed
Soll 2001a
    1. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD000510] - DOI - PubMed
Soll 2001b
    1. Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD000144] - DOI - PubMed
Soll 2004
    1. Soll RF. Prophylactic natural surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD000511] - DOI - PMC - PubMed
Soll 2009
    1. Soll Roger, Morley Colin J. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD000510] - DOI - PubMed
Soll 2009a
    1. Soll RF, Ozek E. Multiple versus single dose natural surfactant extract for severe neonatal respiratory distress syndrome. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD000141] - DOI - PubMed
Taeusch 2000
    1. Taeusch HW. Treatment of acute (Adult) respiratory distress syndrome. The holy grail of surfactant therapy. Biology of the Neonate 2000;77:2‐8. - PubMed
Talati 2001
    1. Talati AJ, Crouse DT, English BK, Newman C, Harrison L, Meals E. Immunomodulation by exogenous surfactant: effect on TNF‐alpha secretion and luminol‐enhanced chemiluminescence activity by murine macrophages stimulated with group B streptococci. Microbes and infection / Institut Pasteur 2001;3:267‐73. - PubMed
Ventre 2006
    1. Ventre K, Haroon M, Davison C. Surfactant therapy for bronchiolitis in critically ill infants. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD005150.pub2] - DOI - PubMed
Verboon‐Maciolek 2006
    1. Verboon‐Maciolek MA, Thijsen SF, Hemels MA, Menses M, Loon AM, Krediet TG, et al. Inflammatory mediators for the diagnosis and treatment of sepsis in early infancy. Pediatric Research 2006;59:457‐61. - PubMed
Webber 1990
    1. Webber S, Wilkinson AR, Lindsell D, Hope PL, Dobson SR, Isaacs D. Neonatal pneumonia. Archives of Disease in Childhood 1990;65:207‐11. - PMC - PubMed
Yuan 2007
    1. Yuan TM, Chen LH, Yu HM. Risk factors and outcomes for ventilator‐associated pneumonia in neonatal intensive care unit patients. Journal of Perinatal Medicine 2007;35:334‐8. - PubMed

Publication types

Substances

LinkOut - more resources